Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    New revision entry v3.5.2 added and v3.5.0 removed from the history.
    Difference
    0.1%
    Check dated 2026-04-16T11:53:35.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T20:17:54.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The history shows a new revision v3.4.3 was added and v3.4.2 removed, updating the version history display.
    Difference
    0.1%
    Check dated 2026-03-11T18:17:54.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-notice banner and Revision: v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T10:30:55.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A government funding notice banner and a software revision tag (v3.4.1) were added, with no changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T06:22:35.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    UI updates to the history view introduce a glossary toggle, color-coded highlights for additions (green) and deletions (red), and revised revision labels (e.g., Revision: v3.4.0) and No FEAR Act Data wording.
    Difference
    0.8%
    Check dated 2026-01-28T04:18:31.000Z thumbnail image

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.